Stay updated with breaking news from Recursion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $8.66, for a total transaction of $25,980.00. Following the completion of the sale, the chief operating officer now directly owns 418,782 […]
/PRNewswire/ -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.com's offering. The current...
Platinum Investment Management Ltd. grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,770,451 shares of the company’s stock after buying an additional 60,112 shares during the period. Platinum Investment Management Ltd.’s […]
You'll need to dig into company details, but the effort is worthwhile.